This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

TAK-931

Takeda Pharmaceutical Company Ltd

Drug Names(s): TAK931, TAK 931

Description: TAK-931 is a proprietary cell division cycle 7 (CDC7) inhibitor.


TAK-931 News


Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug